ARMISTICE CAPITAL, LLC purchased 1.4% of their position (645K shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $642.9K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 1/11/2022ACC: 0000899243-22-001618
Director10% Owner
Since Jun 2018
+645K
Net shares
Net buyer
$642.9K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
645K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+137.90K
Price / share
$1.04
Trade value
$142.97K
% of position
0.3%
1/7/2022
45M→45.14M
Common Stock
Indirect
Shares
+491.10K
Price / share
$0.99
Trade value
$484.61K
% of position
1.1%
1/10/2022
45.14M→45.63M
Common Stock
Indirect
Shares
+16K
Price / share
$0.96
Trade value
$15.34K
% of position
0.0%
1/11/2022
45.63M→45.65M
Total
Net shares
+645K
Net value
$642.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/7/2022 | P · Purchase | +137.90K | $1.04 | $142.97K | 0.3% | 45M | 45.14M |
| Common Stock Indirect | 1/10/2022 | P · Purchase | +491.10K | $0.99 | $484.61K | 1.1% | 45.14M | 45.63M |
| Common Stock Indirect | 1/11/2022 | P · Purchase | +16K | $0.96 | $15.34K | 0.0% | 45.63M | 45.65M |
| Total | +645K | $642.93K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned412.44K
Total
412.44K direct412.44K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 412.44K | Direct |
| Total | 412.44K | 412.44K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported